Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates

Core Viewpoint - Mesa Labs reported quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share, and down from $2.77 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was -18.91%, with the company previously expected to post earnings of $2.45 per share but actually reporting $2.67 per share in the prior quarter, resulting in a positive surprise of 8.98% [2] - Revenues for the quarter were $62.14 million, missing the Zacks Consensus Estimate by 1.53%, compared to $58.9 million in the same quarter last year [3] - Over the last four quarters, Mesa Labs has surpassed consensus revenue estimates two times [3] Stock Performance - Mesa Labs shares have declined approximately 14.2% since the beginning of the year, while the S&P 500 has gained 0.7% [4] - The current Zacks Rank for Mesa Labs is 3 (Hold), indicating expected performance in line with the market in the near future [7] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.80 on revenues of $61.3 million, and for the current fiscal year, it is $11.35 on revenues of $255.3 million [8] - The trend of estimate revisions for Mesa Labs is mixed, which may change following the recent earnings report [7] Industry Context - The Medical - Instruments industry, to which Mesa Labs belongs, is currently in the top 35% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [9]